V-FAST master trial: Preliminary results of treatment with CPX-351 plus midostaurin in adults with newly diagnosed FLT3-mutated acute myeloid leukemia.

Authors

null

James K. McCloskey

John Theurer Cancer Center, Hackensack University Medical Center, Hackensack, NJ

James K. McCloskey , Vinod A. Pullarkat , Gabriel N. Mannis , Tara L. Lin , Stephen Anthony Strickland , Amir Tahmasb Fathi , Harry Paul Erba , Stefan Faderl , Divya Chakravarthy , Yana Lutska , Vijayalakshmi Chandrasekaran , Ronald Cheung , Mark J. Levis

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2022 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Hematologic Malignancies—Leukemia, Myelodysplastic Syndromes, and Allotransplant

Track

Hematologic Malignancies

Sub Track

Acute Leukemia

Clinical Trial Registration Number

NCT04075747

Citation

J Clin Oncol 40, 2022 (suppl 16; abstr 7043)

DOI

10.1200/JCO.2022.40.16_suppl.7043

Abstract #

7043

Poster Bd #

274

Abstract Disclosures

Similar Posters

First Author: Vinod Pullarkat

First Author: Geoffrey L. Uy

First Author: Richard M. Stone

First Author: Varada Salimath